ERS statement on chronic thromboembolic pulmonary hypertension
Universitair Ziekenhuis Leuven · KU Leuven · +27 more institutions
Indexed incrossrefpubmed
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries by fibrotic intravascular material, in combination with a secondary microvasculopathy of vessels
Citation impact
527
total citations
- FWCI
- 36.32
- Percentile
- 100%
- References
- 221
Citations per year
Authors
29- MDMarion DelcroixCorresponding
Universitair Ziekenhuis Leuven, KU Leuven
- ATAdam Torbicki
Council of Science Editors
- DGDeepa Gopalan
Council of Science Editors
- OSOlivier Sitbon
Inserm, Université Paris-Saclay, Council of Science Editors, Assistance Publique – Hôpitaux de Paris, Bicêtre Hospital
- FAFrederikus A. Klok
Leiden University Medical Center, Council of Science Editors
Topics & keywords
Topics
Keywords
- Medicine
- Pulmonary hypertension
- Angioplasty
- Pulmonary embolism
- Cardiology
- Internal medicine
- Intensive care medicine
- Radiology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- BBayer
- GGlaxoSmithKline
- SSanofi
- UTUnited Therapeutics Corporation
- EREuropean Respiratory SocietyAward: TF 2018-04
- AAcceleron
- NSNippon Shinyaku
- DFDeutsche Forschungsgemeinschaft
- ANAgence Nationale de la RechercheAwards: 18-RHUS-0006, 2017-, ANR-18, ANR-18-RHUS-0006
- DDaiichi-Sankyo
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAwards: 918.16.610, NWO-VICI: 918.16.610
- AOAOP Orphan
- PJPfizer Japan
- BYBayer Yakuhin
- APActelion Pharmaceuticals